DURECT Corporation Presenting at the Acumen BioFin Rodman & Renshaw 4th Annual Global Healthcare Conference

Download PDF:

CUPERTINO, Calif., May 8 /PRNewswire-FirstCall/ — DURECT Corporation
(Nasdaq: DRRX) announced today that it would present at the Acumen BioFin
Rodman & Renshaw 4th Annual Global Healthcare Conference to be held on
May 14-15 at the Le Meridien Beach Plaza Hotel in Monte Carlo, Monaco. James
E. Brown, President and CEO, will be presenting at the conference on May 14th
at 10:00 a.m. Eastern Time / 4:00 p.m. Central European Time.

(Logo: http://www.newscom.com/cgi-bin/prnh/20020717/DRRXLOGO )

A live audio webcast of the presentation will be available by accessing
DURECT’s homepage at www.www.durect.com and clicking “Investor Relations.” If you
are unable to participate during the live webcast, the call will be archived
on DURECT’s website under Audio Archive in the “Investor Relations” section.

About DURECT Corporation

DURECT Corporation is an emerging specialty pharmaceutical company
developing pharmaceutical systems based on its proprietary drug delivery
platform technologies. The Company currently has a number of late-stage
pharmaceutical products in development addressing large markets in pain
management, with a number of research programs underway targeting chronic
disease and other therapeutic areas. For more information, please visit
www.www.durect.com .

CONTACT: Matthew J. Hogan, Chief Financial Officer of DURECT
Corporation, +1-408-777-4936; or media, Jeremiah Hall, Senior Vice President
of Feinstein Kean Healthcare, +1-415-677-2700, jeremiah.hall@fkhealth.com
Photo: NewsCom: http://www.newscom.com/cgi-bin/prnh/20020717/DRRXLOGO
AP Archive: http://photoarchive.ap.org
PRN Photo Desk, photodesk@prnewswire.com
Web site: http://www.www.durect.com

Scroll to Top